Impact of antihypertensive combination and monotreatments on blood pressure variability: Assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database

Journal of Hypertension

Volumn 32, Issue 6, 2014, Pages 1326-1333

  Parati, Gianfranco ^a,b   Dolan, Eamon ^c   Ley, Ludwin ^d   Schumacher, Helmut ^d  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c Royal College of Surgeons in Ireland   (Ireland)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

antihypertensive treatment; blood pressure variability; hypertension; smoothness index

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS TELMISARTAN; PLACEBO; RAMIPRIL; TELMISARTAN; VALSARTAN; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; DRUG COMBINATION;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR PARAMETERS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DATA BASE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; SMOOTHNESS INDEX; SYSTOLIC BLOOD PRESSURE; TREATMENT ON VARIABILITY INDEX; AGED; ALGORITHM; BLOOD PRESSURE; CLINICAL TRIAL (TOPIC); DRUG COMBINATION; DRUG EFFECTS; FACTUAL DATABASE; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AGED; ALGORITHMS; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84900445981     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000169     Document Type: Article

References (35)

1. Eto M, Toba K, Akishita M, Kozaki K, Watanabe T, Kim S, et al. Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res 2005; 28:1-7.
2. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic value of reading-to-reading blood pressure variability over 24 h in 8938 subjects from 11 populations. Hypertension 2010; 55:1049-1057.
3. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36:901-906.
4. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001; 19:1981-1989.
5. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007; 49:1265-1270.
6. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-h blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5:93-98.
7. Stolarz-Skrzypek K, Thijs L, Li Y, Hansen TW, Boggia J, Kuznetsova T, et al. Short-term blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO). Acta Cardiol 2011; 66:701-706.
8. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013; 10:143-155.
9. Gosse P, Neutel JM, Schumacher H, Lacourciere Y, Williams B, Davidai G the effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials. Blood Press Monit 2007; 12:141-147.
10. Iqbal P, Stevenson L. Cardiovascular outcomes in patients with normal and abnormal 24-h ambulatory blood pressure monitoring. Int J Hyper-tens 2010; 2011:786912.
11. Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Ramundo E, Gentile G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 2012; 60:34-42.
12. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006; 47:149-154.
13. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189.
14. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
15. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G the smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16:1685-1691.
16. Rizzoni D, Muiesan ML, Salvetti M, Castellano M, Bettoni G, Monteduro C, et al the smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihyperten-sive treatment. J Hypertens 2001; 19:703-711.
17. Parati G, Schumacher H, Bilo G, Mancia G. Evaluating 24-h anti-hypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database. J Hypertens 2010; 28:2177-2183.
18. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53:96-104.
19. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480.
20. Xie HH, Shen FM, Xu LP, Han P, Miao CY, Su DF. Reduction of blood pressure variability by combination therapy in spontaneously hypertensive rats. J Hypertens 2007; 25:2334-2344.
21. Xie HH, Zhang XF, Chen YY, Shen FM, Su DF. Synergism of hydro-chlorothiazide and nifedipine on blood pressure variability reduction and organ protection in spontaneously hypertensive rats. Hypertens Res 2008; 31:685-691.
22. White WB, Littlejohn TW, Majul CR, Oigman W, Olvera R, Seeber M, et al. Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension. Blood Press Monit 2010; 15:205-212.
23. Schillaci G, Bilo G, Pucci G, Laurent S, Macquin-Mavier I, Boutouyrie P, et al. Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 2012; 60:369-377.
24. Gerin W, Rosofsky M, Pieper C, Pickering TG. A test of reproducibility of blood pressure and heart rate variability using a controlled ambulatory procedure. J Hypertens 1993; 11:1127-1131.
25. Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2005; 23:505-511.
26. Bilo G, Giglio A, Styczkiewicz K, Caldara G, Maronati A, Kawecka-Jaszcz K, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 2007; 25:2058-2066.
27. Ding PY, Chu KM, Chiang HT, Shu KH. A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40mg in comparison with losartan 50mg in the treatment of mild-to-moderate hypertension in Taiwanese patients. Int J Clin Pract Suppl 2004;16-22.
28. Lacourciere Y, Krzesinski JM, White WB, Davidai G, Schumacher H. Sustained antihypertensive activity of telmisartan compared with val-sartan. Blood Press Monit 2004; 9:203-210.
29. Nalbantgil I, Nalbantgil S, Ozerkan F, Yilmaz H, Gurgun C, Zoghi M, et al the efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension. Int J Clin Pract Suppl 2004;50-54.
30. Ferrucci A, Marcheselli A, Strano S, Ciavarella G, Messa F, Calcagnini G. 24-hour blood pressure profiles in patients with hypertension treated with amlodipine or nifedipine GITS. Clin Drug Invest 1997; 13:67-72.
31. Scholz H. Pharmacological aspects of calcium channel blockers. Car-diovasc Drugs Ther 1997; 10 (Suppl 3):869-872.
32. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:895-905.
33. Calvo C, Hermida RC, Ayala DE, Ruilope LM. Effects of telmisartan 80mg and valsartan 160mg on ambulatory blood pressure in patients with essential hypertension. J Hypertens 2004; 22:837-846.
34. Destro M, Scabrosetti R, Vanasia A, Mugellini A. Comparative efficacy of valsartan and olmesartan in mild-to-moderate hypertension: results of 24-h ambulatory blood pressure monitoring. Adv Ther 2005; 22:32-43.
35. Liu JG, Xu LP, Chu ZX, Miao CY, Su DF. Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens 2003; 21:1961-1967.